MANAGEMENT OF MYELODYSPLASTIC SYNDROMES
- 1 June 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2), 191-196
- https://doi.org/10.1111/j.1365-2141.1993.tb03051.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- THERAPY WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMESBritish Journal of Haematology, 1992
- DESFERRIOXAMINE TREATMENT REDUCES BLOOD TRANSFUSION REQUIREMENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMEBritish Journal of Haematology, 1992
- Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicityEuropean Journal of Cancer and Clinical Oncology, 1991
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- BONE MARROW TRANSPLANTATION USING UNRELATED DONORS FOR PATIENTS WITH ADVANCED LEUKEMIA OR BONE MARROW FAILURETransplantation, 1990
- Chronic Myelomonocytic Leukemia: Natural History and Prognostic DeterminantsMayo Clinic Proceedings, 1989
- TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA WITH LOW DOSE ETOPOSIDEBritish Journal of Haematology, 1989
- Effectiveness of attenuated chemotherapy in myelodysplastic syndromes: A preliminary reportMedical and Pediatric Oncology, 1988
- Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cellsInternational Journal of Cancer, 1980
- Refractory Anaemia with Excess of Myeloblasts in the Bone Marrow: a Clinical Trial of Androgens in 90 PatientsBritish Journal of Haematology, 1977